Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study

被引:0
|
作者
Hinga, Alex [1 ]
Ibrahim, Akram [2 ]
Vintimilla, Diego [3 ]
Jones, Mickayla [2 ]
Eckstein, Lisa [4 ]
Rid, Annette [5 ,6 ]
Shah, Seema K. [2 ,7 ]
Kamuya, Dorcas [1 ,8 ]
机构
[1] KEMRI Wellcome Trust Res Programme, Hlth Syst & Res Eth, Nairobi, Kenya
[2] Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Mary Ann & J Milburn Smith Child Hlth Outcomes Res, Chicago, IL USA
[3] Chicago Dept Publ Hlth, Chicago, IL USA
[4] Univ Tasmania, Sch Law, Hobart, Tas, Australia
[5] NIH, Clin Ctr, Dept Bioeth, Bethesda, MD USA
[6] NIH, Fogarty Int Ctr, Div Int Sci Policy Planning & Evaluat, Bethesda, MD USA
[7] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL USA
[8] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England
来源
BMJ GLOBAL HEALTH | 2024年 / 9卷 / 08期
基金
美国国家卫生研究院;
关键词
Global Health; Qualitative study; Clinical trial; Decision Making; Descriptive study; SAFETY; BOARDS; ISSUES;
D O I
10.1136/bmjgh-2024-015233
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction A data monitoring committee (DMC) is an independent group of experts who assess the ongoing scientific and ethical integrity of a study through periodic analyses of study data. The objective of this study was to explore the extent to which the structure, membership and deliberations of DMCs enable them to address ethical issues.Methods We conducted qualitative individual interviews (n=22) with DMC members from countries across Africa, the Americas, South Asia and the UK. We selected interview respondents through purposive sampling, managed data using NVivo (Release V.1.7) and analysed data thematically.Results All respondents were highly experienced professionals; many (18/22) had received training in medicine and/or statistics. One respondent had academic qualifications in ethics, and four indicated that they served on DMCs as ethicists. While respondents generally felt DMCs should be required for studies that were high-risk or enrolled vulnerable populations, some were concerned about the overuse of DMCs. There were divergent views on the necessity of geographical and disciplinary representation in DMC membership, including about whether ethicists were helpful. Many respondents described a DMC member recruitment process that they felt was somewhat exclusive. While one respondent received DMC-specific training, most described learning on the job. Respondents generally agreed that study protocols and DMC charters were key guiding documents for addressing ethical issues and described DMC deliberations that often, but not always, involved consensus-building.Conclusion This study is one of the first to consider the ethical implications of DMC structure, membership and deliberations. The potential overuse of DMCs, DMC member recruitment processes that seem somewhat insular, limited training for DMC members, and divergent approaches to deliberation may limit the capacity of DMCs for addressing ethical issues. Further research on DMC structure and processes could help enhance the ethical preparedness of DMCs.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials
    Schoffski, P.
    BMJ OPEN, 2021, 11 (10):
  • [22] ENHANCING TRIAL INTEGRITY BY PROTECTING THE INDEPENDENCE OF DATA MONITORING COMMITTEES IN CLINICAL TRIALS
    Fleming, Thomas R.
    Hennekens, Charles H.
    Pfeffer, Marc A.
    DeMets, David L.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (05) : 968 - 975
  • [23] Data monitoring committees for clinical trials evaluating treatments of COVID-19
    Muetze, Tobias
    Friede, Tim
    CONTEMPORARY CLINICAL TRIALS, 2020, 98
  • [24] Enhancing the Scientific Integrity and Safety of Clinical Trials Recommendations for Data Monitoring Committees
    Lewis, Roger J.
    Calis, Karim A.
    DeMets, David L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (22): : 2359 - 2360
  • [25] A SURVEY OF MONITORING PRACTICES IN CANCER CLINICAL-TRIALS - DATA MONITORING COMMITTEES FOR SOUTHWEST ONCOLOGY GROUP CLINICAL-TRIALS - DISCUSSION
    ELLENBERG, S
    CROWLEY, J
    MEINERT, C
    GEORGE, S
    POCOCK, S
    ARMITAGE, P
    SIMON, R
    YUSUF, S
    WITTES, J
    STATISTICS IN MEDICINE, 1993, 12 (5-6) : 457 - 459
  • [26] Stopping clinical trials early - Data monitoring committees may have important role
    Grant, A
    BRITISH MEDICAL JOURNAL, 2004, 329 (7465): : 525 - 526
  • [27] Data Monitoring Committees in Clinical Trials: A Practical Perspective 2nd ed
    Barker, Chris
    AMERICAN STATISTICIAN, 2022, 76 (03): : 305 - 306
  • [28] Data management in diabetes clinical trials: a qualitative study
    Aynaz Nourani
    Haleh Ayatollahi
    Masoud Solaymani Dodaran
    Trials, 23
  • [29] Data management in diabetes clinical trials: a qualitative study
    Nourani, Aynaz
    Ayatollahi, Haleh
    Dodaran, Masoud Solaymani
    TRIALS, 2022, 23 (01)
  • [30] Factors that influence community hospital involvement in clinical trials: A qualitative descriptive study
    Wang, Mei
    Dolovich, Lisa
    Holbrook, Anne
    Jack, Susan M.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2022, 28 (01) : 79 - 85